Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs (Q35836781)

10 August 2017

Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs (English)

1 reference

sexually transmitted infection

10 August 2017

0 references

0 references

0 references

1 reference

1 reference

Lawrence S Brown

1

1 reference

10 August 2017

Steven Kritz

2

1 reference

10 August 2017

R Jeffrey Goldsmith

3

1 reference

10 August 2017

Edmund J Bini

4

1 reference

10 August 2017

Jim Robinson

5

1 reference

10 August 2017

Donald Alderson

6

1 reference

10 August 2017

John Rotrosen

7

1 reference

10 August 2017

language of work or name

1 reference

1 July 2007

1 reference

10 August 2017

Public Health Reports

1 reference

10 August 2017

122

1 reference

10 August 2017

4

1 reference

10 August 2017

441-451

1 reference

Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Drug abuse treatment as an HIV prevention strategy: a review

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV infection among drug users attending an STD/HIV prevention and needle-exchange program in Quebec City, Canada

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Drug abuse treatment as AIDS prevention.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Prevalence and incidence of hepatitis C virus infection among young adult injection drug users

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Medical care for injection-drug users with human immunodeficiency virus infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Correlates of hepatitis C virus infections among injection drug users.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Role of drug-abuse treatment in limiting the spread of AIDS.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Methadone treatment and acquired immunodeficiency syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Treatment Outcome Prospective Study (TOPS): client characteristics and behaviors before, during, and after treatment.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1888517

Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif

24 September 2018

1 reference

12 December 2020

A nationwide survey of hepatitis C services provided by drug treatment programs

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention

1 reference

12 December 2020

Substance abuse and HIV infection

1 reference

12 December 2020

Differences in HIV disease progression by injecting drug use in HIV-infected persons in care

1 reference

12 December 2020

Epidemiology of HIV/AIDS--United States, 1981-2005

1 reference

12 December 2020

Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility

1 reference

12 December 2020

10.1177/003335490712200404

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

17639646

1 reference